The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_2618	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro resultNo cell growth suppression after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2619	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result10% cell growth suppression after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2620	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result10% cell growth suppression after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2621	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result20% cell growth suppression after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2622	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result10% cell growth suppression after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2623	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result10% cell growth suppression after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2624	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro resultNo cell growth suppression after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2625	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result15% cell growth suppression after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2626	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result20% cell growth suppression after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2627	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result20% cell growth suppression after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2628	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result5% cell growth suppression after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823
IDOV_2629	Virus nameAdenovirus	Virus strainAd-hTERT-E1a-Apoptin	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of E1a and apoptin before hTERT promoter	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineType culture collection of chines academy, shanghai	Origin of cell lineHuman gastric cancer cell line	Cell lineGES-1	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result15% cell growth suppression after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis in cancer	Immunogenic effectNA	Clinical trialNA	PMID22842823